Evidence map›Paper›PMID 38969718›Full record

ArticleCommunications chemistry2024

Time-resolved crystallography of boric acid binding to the active site serine of the β-lactamase CTX-M-14 and subsequent 1,2-diol esterification.

Andreas Prester, Markus Perbandt, Marina Galchenkova, Dominik Oberthuer, Nadine Werner, Alessandra Henkel, Julia Maracke, Oleksandr Yefanov, Johanna Hakanpää, Guillaume Pompidor and 6 more

Abstract read
In one paragraph

Article in Communications chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Fused 3D boron heterocyclesChemical science · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Challenges of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025
    Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Andreas PresterInstitute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf UKE, Hamburg, Germany.ORCID http://orcid.org/0000-0003-2738-7682
Markus PerbandtInstitute of Biochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany.ORCID http://orcid.org/0000-0001-7517-8522
Marina GalchenkovaCenter for Free-Electron Laser Science CFEL, DESY, Hamburg, Germany.
Dominik OberthuerCenter for Free-Electron Laser Science CFEL, DESY, Hamburg, Germany.ORCID http://orcid.org/0000-0002-0894-9590
Nadine WernerInstitute of Biochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany.
Alessandra HenkelCenter for Free-Electron Laser Science CFEL, DESY, Hamburg, Germany.ORCID http://orcid.org/0000-0002-9288-5373
Julia MarackeCenter for Free-Electron Laser Science CFEL, DESY, Hamburg, Germany.
Oleksandr YefanovCenter for Free-Electron Laser Science CFEL, DESY, Hamburg, Germany.
Johanna HakanpääDeutsches Elektronen-Synchrotron DESY, Hamburg, Germany.
Guillaume PompidorDeutsches Elektronen-Synchrotron DESY, Hamburg, Germany.
Jan MeyerDeutsches Elektronen-Synchrotron DESY, Hamburg, Germany.
Henry ChapmanCenter for Free-Electron Laser Science CFEL, DESY, Hamburg, Germany.ORCID http://orcid.org/0000-0002-4655-1743
Martin AepfelbacherInstitute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf UKE, Hamburg, Germany.
Winfried HinrichsInstitute of Biochemistry, University of Greifswald, Greifswald, Germany.ORCID http://orcid.org/0000-0002-0435-4565
Holger RohdeInstitute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf UKE, Hamburg, Germany. rohde@uke.de.ORCID http://orcid.org/0000-0001-8587-4433
Christian BetzelInstitute of Biochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany. christian.betzel@uni-hamburg.de.ORCID http://orcid.org/0000-0002-3879-5019

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 05K19GU4Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 05K20GUBDeutsche Forschungsgemeinschaft (German Research Foundation) 390715994Joachim Herz Stiftung (Joachim Herz Foundation) Infecto-physics
6 · The paper itself

Abstract

The emergence and spread of antibiotic resistance represent a growing threat to public health. Of particular concern is the appearance of β-lactamases, which are capable to hydrolyze and inactivate the most important class of antibiotics, the β-lactams. Effective β-lactamase inhibitors and mechanistic insights into their action are central in overcoming this type of resistance, and in this context boronate-based β-lactamase inhibitors were just recently approved to treat multidrug-resistant bacteria. Using boric acid as a simplified inhibitor model, time-resolved serial crystallography was employed to obtain mechanistic insights into binding to the active site serine of β-lactamase CTX-M-14, identifying a reaction time frame of 80-100 ms. In a next step, the subsequent 1,2-diol boric ester formation with glycerol in the active site was monitored proceeding in a time frame of 100-150 ms. Furthermore, the displacement of the crucial anion in the active site of the β-lactamase was verified as an essential part of the binding mechanism of substrates and inhibitors. In total, 22 datasets of β-lactamase intermediate complexes with high spatial resolution of 1.40-2.04 Å and high temporal resolution range of 50-10,000 ms were obtained, allowing a detailed analysis of the studied processes. Mechanistic details captured here contribute to the understanding of molecular processes and their time frames in enzymatic reactions. Moreover, we could demonstrate that time-resolved crystallography can serve as an additional tool for identifying and investigating enzymatic reactions.

Identifiers

PMID38969718
PMCPMC11226702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.